Patent Assignment
Reel/Frame 057634/0112
Assignment of Assignor's Interest
Recorded: 2021-09-29
Pages: 4
Assignor
KEEFE, DENNIS
Executed: 2015-07-02
Assignee
SHIRE HUMAN GENETIC THERAPIES, INC.
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties
(4)
Anti-Flt-1 Antibodies for Treating Duchenne Muscular Dystrophy
Anti-Flt-1 Antibodies for Treating Duchenne Muscular Dystrophy
Application:
16/991,762 →
Publication:
US 2021/0206860
Anti-Flt-1 Antibodies for Treating Duchenne Muscular Dystrophy
Application:
62/144,251 →
Anti-Flt-1 Antibodies for Treating Duchenne Muscular Dystrophy
Application:
62/307,645 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 30, 2016
From: KEEFE, DENNIS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 038141/0527 →
Assignment of Assignor's Interest
Apr 6, 2016
From: KEEFE, DENNIS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 038201/0709 →
Assignment of Assignor's Interest
Mar 30, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 055766/0572 →
Assignment of Assignor's Interest
Jun 3, 2021
From: SHIRE HUMAN GENETIC THERAPIES, INC.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056420/0964 →
Assignment of Assignor's Interest
Sep 28, 2021
From: KEEFE, DENNIS
To: SHIRE HUMAN GENETIC THERAPIES, INC.
Reel/Frame 057620/0972 →